GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Short Interest

Covalon Technologies (TSXV:COV) Short Interest


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Covalon Technologies's Short Interest

For the Biotechnology subindustry, Covalon Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Covalon Technologies's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Short Interest falls into.


Covalon Technologies (TSXV:COV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Short Interest
Comparable Companies
NEOE:BMND XCNQ:DOSE TSX:APS TSXV:TTI XCNQ:PHRM TSXV:CZO XCNQ:GLAB TSXV:GSD XCNQ:TELI XCNQ:MDMA OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
CVALF:USA
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Website
https://www.covalon.com
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies (TSXV:COV) Headlines

No Headlines